Jacob A, He J, Peck A, Jamil A, Bunya V, Alexander J
Heliyon. 2025; 11(1):e41082.
PMID: 39801970
PMC: 11720936.
DOI: 10.1016/j.heliyon.2024.e41082.
Caraba A, Roman D, Crisan V, Iurciuc S, Iurciuc M
Int J Mol Sci. 2025; 26(1.
PMID: 39795957
PMC: 11720050.
DOI: 10.3390/ijms26010101.
Yang Z, Liu M, Chang Z, Du C, Yang Y, Zhang C
Front Immunol. 2024; 15:1465938.
PMID: 39497829
PMC: 11532040.
DOI: 10.3389/fimmu.2024.1465938.
Ghahramani Almanghadim H, Karimi B, Valizadeh S, Ghaedi K
Noncoding RNA Res. 2024; 10:70-90.
PMID: 39315339
PMC: 11417496.
DOI: 10.1016/j.ncrna.2024.09.001.
Liao J, Yu X, Huang Z, He Q, Yang J, Zhang Y
Front Immunol. 2024; 15:1345381.
PMID: 38736890
PMC: 11082322.
DOI: 10.3389/fimmu.2024.1345381.
Pulmonary Involvement in Sjögren's Syndrome: Correlations with Biomarkers of Activity and High-Resolution Computer Tomography Findings.
Roman D, Iurciuc S, Caraba A
J Clin Med. 2024; 13(4).
PMID: 38398414
PMC: 10889824.
DOI: 10.3390/jcm13041100.
Inflammatory cytokines and their potential role in Sjogren's syndrome risk: insights from a mendelian randomization study.
Shi W, Xu Y, Zhang A, Jia X, Liu S, Hu Z
Adv Rheumatol. 2024; 64(1):14.
PMID: 38365917
DOI: 10.1186/s42358-024-00354-2.
Network pharmacology-based strategy to investigate the mechanisms of artemisinin in treating primary Sjögren's syndrome.
Liao J, He Q, Huang Z, Yu X, Yang J, Zhang Y
BMC Immunol. 2024; 25(1):16.
PMID: 38347480
PMC: 10860289.
DOI: 10.1186/s12865-024-00605-3.
Manifestations and management of Sjögren's disease.
Maleki-Fischbach M, Kastsianok L, Koslow M, Chan E
Arthritis Res Ther. 2024; 26(1):43.
PMID: 38331820
PMC: 10851604.
DOI: 10.1186/s13075-024-03262-4.
Current developments and opportunities of pluripotent stem cells-based therapies for salivary gland hypofunction.
Song W, Liu H, Su Y, Zhao Q, Wang X, Cheng P
Front Cell Dev Biol. 2024; 12:1346996.
PMID: 38313227
PMC: 10834761.
DOI: 10.3389/fcell.2024.1346996.
Lessons from Animal Models in Sjögren's Syndrome.
Mieliauskaite D, Kontenis V, Siaurys A
Int J Mol Sci. 2023; 24(16).
PMID: 37629175
PMC: 10454747.
DOI: 10.3390/ijms241612995.
Sjögren's Syndrome Treatments in the Microbiome Era.
Freguia C, Pascual D, Fanger G
Adv Geriatr Med Res. 2023; 5(2).
PMID: 37323129
PMC: 10270702.
DOI: 10.20900/agmr20230004.
Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren's syndrome.
Kawka L, Felten R, Schleiss C, Fauny J, Van Quyen P, Dumortier H
RMD Open. 2023; 9(2).
PMID: 37230761
PMC: 10230975.
DOI: 10.1136/rmdopen-2023-003051.
Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management.
Donthineni P, Doctor M, Shanbhag S, Kate A, Galor A, Djalilian A
Indian J Ophthalmol. 2023; 71(4):1332-1347.
PMID: 37026265
PMC: 10276701.
DOI: 10.4103/IJO.IJO_2808_22.
Salivary gland ultrasound is associated with the presence of autoantibodies in patients with Sjögren's syndrome: A Danish single-centre study.
Schmidt N, Voss A, Nilsson A, Terslev L, Just S, Lindegaard H
PLoS One. 2022; 17(12):e0265057.
PMID: 36508457
PMC: 9744271.
DOI: 10.1371/journal.pone.0265057.
Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren's Syndrome?.
Sebastian A, Madej M, Gajdanowicz P, Sebastian M, Luczak A, Zemelka-Wiacek M
J Clin Med. 2022; 11(18).
PMID: 36143051
PMC: 9504735.
DOI: 10.3390/jcm11185405.
Cadherin Signaling in Cancer and Autoimmune Diseases.
Sisto M, Ribatti D, Lisi S
Int J Mol Sci. 2021; 22(24).
PMID: 34948155
PMC: 8704376.
DOI: 10.3390/ijms222413358.